What type of study is this?

This is a Validation Study study.

December 8, 2025Blood

Enhanced IPSS-m: A comorbidity-integrated model for improved clinical risk stratification in myelodysplastic neoplasms

View Full Paper

Ask AI

Bookmark

Authors

Enhanced IPSS-M model improves risk stratification in MDS by integrating comorbidity data, potentially aiding treatment decisions.

Enhanced IPSS-M improves risk stratification accuracy in MDS by incorporating comorbidity metrics.
The model achieved a concordance index of 0.692, significantly outperforming the previous IPSS-M's 0.595.
Machine learning techniques were employed to refine prognostic prediction and patient risk categorization.
Integration of real-world data emphasizes the need for comprehensive risk assessments, enhancing patient management strategies.

Dhillon et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

Enhanced IPSS-M model improves risk stratification in MDS by integrating comorbidity data, potentially aiding treatment decisions.

Enhanced IPSS-M improves risk stratification accuracy in MDS by incorporating comorbidity metrics.
The model achieved a concordance index of 0.692, significantly outperforming the previous IPSS-M's 0.595.
Machine learning techniques were employed to refine prognostic prediction and patient risk categorization.
Integration of real-world data emphasizes the need for comprehensive risk assessments, enhancing patient management strategies.

Dhillon et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark